Abstract
Aim: Hypolipidemic effect of fibrates, mediated by PPARα activation, can be accompanied by liver damage due to oxidative stress and inflammation. Hepatoprotective effect of silymarin was demonstrated in clinical and experimental studies. We investigated whether silymarin improves negative effect of fenofibrate in experimental model of metabolic syndrome, hereditary hypertriglyceridemic rats (HHTg).
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
